Rheb Binds Tuberous Sclerosis Complex 2 (TSC2) and Promotes S6 Kinase Activation in a Rapamycin- and Farnesylation-dependent Manner
Top Cited Papers
Open Access
- 1 August 2003
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 278 (35) , 32493-32496
- https://doi.org/10.1074/jbc.c300226200
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Rheb is a direct target of the tuberous sclerosis tumour suppressor proteinsNature Cell Biology, 2003
- Rheb is an essential regulator of S6K in controlling cell growth in DrosophilaNature Cell Biology, 2003
- Rheb is in a high activation state and inhibits B-Raf kinase in mammalian cellsOncogene, 2002
- mTOR Interacts with Raptor to Form a Nutrient-Sensitive Complex that Signals to the Cell Growth MachineryCell, 2002
- Mutation analysis of the TSC1 and TSC2 genes in Japanese patients with pulmonary lymphangioleiomyomatosisJournal of Human Genetics, 2002
- Farnesylated proteins and cell cycle progressionJournal of Cellular Biochemistry, 2001
- Farnesyltransferase Inhibitor Induces Rapid Growth Arrest and Blocks p70s6k Activation by Multiple StimuliPublished by Elsevier ,2000
- Ribosomal S6 Kinase Signaling and the Control of TranslationExperimental Cell Research, 1999
- Identification of Tuberin, the Tuberous Sclerosis-2 Product. TUBERIN POSSESSES SPECIFIC Rap1GAP ACTIVITYJournal of Biological Chemistry, 1995
- Molecular cloning of a GTPase activating protein specific for the Krev-1 protein p21rap1Cell, 1991